Latest filing published 05 Aug 2024 for Cerevel Therapeutics Holdings, Inc.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Marijn e. Dekkers discloses dealings in 4 companies, chiefly Ginkgo Bioworks Holdings, Inc., Cerevel Therapeutics Holdings, Inc. and Quanterix Corp. We count 14 filings; the first trade dates from 4 June 2021 and the latest from 1 August 2024.
Every open-market trade on record is a sale: 4 sales worth €8.4M. Outside the open market, there are 6 share grants and 3 option exercises. So far in 2024, the count stands at no purchases and 2 sales.
The latest filing, published on 5 August 2024, reports a transaction in Cerevel Therapeutics Holdings, Inc. Typically, a trade is published a median of 4 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
14 of 14 declarations